News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘ProstateCancer’ clear

  • Androgen deprivation therapy — one of the most common treatments for prostate cancer — may increase the risk of death from heart disease in patients over age 65, according to a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women's Hospital and other institutions.

Tags: ProstateCancer

  • Scientists at Dana-Farber report they have blocked the development of prostate tumors in cancer-prone mice by knocking out a molecular unit they described as a "powerhouse" that drives runaway cell growth.

Tags: BasicResearch, ProstateCancer

  • A new blood test increases the accuracy of prostate cancer diagnosis and could eliminate tens of thousands of unneeded prostate biopsies annually, Dana-Farber researchers report.

Tags: BasicResearch, ProstateCancer

  • In prostate cancer patients with a certain genetic variant, a high level of selenium in the blood was associated with a two-fold greater risk of poorer outcomes than men with the lowest amounts of selenium.

Tags: BasicResearch, ProstateCancer

  • Deprived of androgen hormones, the receptor finds an alternative genetic pathway to continue growth of prostate cancer cells. An understanding of this behavior could lead to new therapies targeting specific genes.

Tags: BasicResearch, ProstateCancer, Genetics

  • Nine-fold higher pancreatic cancer risk suggests people with this genetic syndrome should be closely monitored.

Tags: ProstateCancer, Genetics

  • The vaccine, which contained weakened poxviruses genetically programmed to spur an immune system attack on prostate tumor cells, helped patients lived longer than patients who received a placebo vaccine.

Tags: ProstateCancer, TranslationalResearch

  • The FDA's approval of Provenge®, a prostate cancer vaccine, marks a new era of using patients' immune systems to treat cancer.

Tags: ImmuneSystem, ProstateCancer, TranslationalResearch, Immunotherapy

  • Analysis finds higher quality of life for men diagnosed with low-risk prostate cancer who choose ongoing exams over immediate treatment.

Tags: ProstateCancer

  • Prostate tumors that carry a "signature" of four molecular markers have the potential to become dangerously metastatic if not treated aggressively, Dana-Farber Cancer Institute researchers report in an online study published by the journal Nature.

Tags: ProstateCancer, Genetics

Showing 1-10 of 21 items